Production and characterization of mouse monoclonal antibodies to wild-type and oncogenic FLI-1 proteins.

THOMAS MELOT , NADÈGE GRUEL , ALEXANDRE DOUBEIKOVSKI , NICOLAS SEVENET
Hybridoma 16 ( 5) 457 -464

25
1997
A New Set of Monoclonal Antibodies Against Human FcγRII (CD32) and FcγRIII (CD16): Characterization and Use in Various Assays

FREDERIC VELY , NADEGE GRUEL , JANINE MONCUIT , OLIVIER COCHET
Hybridoma 16 ( 6) 519 -528

54
1997
Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments

Claude Caron de Fromentel , Nadége Gruel , Corinne Venot , Laurent Debussche
Oncogene 18 ( 2) 551 -557

77
1999
PURIFICATION OF SOLUBLE RECOMBINANT HUMAN FcγRII (CD32)

N. Gruel1* , J. Chapiro1* , W. Fridman , J.-L. Teillaud
Preparative Biochemistry & Biotechnology 31 ( 4) 341 -354

4
2001
Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast

Anne Vincent-Salomon , Carlo Lucchesi , Nadège Gruel , Virginie Raynal
Clinical Cancer Research 14 ( 7) 1956 -1965

125
2008
Biotechnologie: un avenir pour les thérapeutiques:-pathologie-les biotechnologies au service de la thérapeutique

Nadège GRUEL , Jean-Luc TEILLAUD , Guilan VODJDANI
OBJECTIF SOINS ( 51) 27 -34

1997
Neoadjuvant Everolimus for Adult Giant Mesenteric Cystic Lymphangioma with mTOR Pathway Activation.

Nadège Gruel , Olivier Mir , Sylvie Bonvalot , Sarah Watson
Oncologist

2021
First description of a sporadic breast cancer in a woman with BRCA1 germline mutation

Elsa Curtit , Vanessa Benhamo , Nadège Gruel , Tatiana Popova
Oncotarget 6 ( 34) 35616 -35624

6
2015
Gene expression profiling of 1p35-36 genes in neuroblastoma.

Isabelle Janoueix-Lerosey , Eugene Novikov , Marta Monteiro , Nadège Gruel
Oncogene 23 ( 35) 5912 -5922

52
2004
Characterization of the Recurrent 8p11-12 Amplicon Identifies PPAPDC1B, a Phosphatase Protein, as a New Therapeutic Target in Breast Cancer

Isabelle Bernard-Pierrot , Nadège Gruel , Nicolas Stransky , Anne Vincent-Salomon
Cancer Research 68 ( 17) 7165 -7175

100
2008
High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Elodie Manié , Anne Vincent-Salomon , Jacqueline Lehmann-Che , Gaelle Pierron
Cancer Research 69 ( 2) 663 -671

134
2009
PPAPDC1B and WHSC1L1 Are Common Drivers of the 8p11-12 Amplicon, Not Only in Breast Tumors But Also in Pancreatic Adenocarcinomas and Lung Tumors

Sardar F. Mahmood , Nadège Gruel , Rémy Nicolle , Elodie Chapeaublanc
American Journal of Pathology 183 ( 5) 1634 -1644

29
2013
Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression

Pierre Romero , Vanessa Benhamo , Gabrielle Deniziaut , Laetitia Fuhrmann
American Journal of Pathology 188 ( 10) 2378 -2391

2
2018
LIN7A is a major determinant of cell-polarity defects in breast carcinomas

Nadège Gruel , Laetitia Fuhrmann , Catalina Lodillinsky , Vanessa Benhamo
Breast Cancer Research 18 ( 1) 23 -23

8
2016
A tumor specific single chain antibody dependent gene expression system.

Marie-Noëlle Mary , Corinne Venot , Claude Caron de Fromentel , Laurent Debussche
Oncogene 18 ( 2) 559 -564

7
1999
Polarity gene alterations in pure invasive micropapillary carcinomas of the breast

Nadège Gruel , Vanessa Benhamo , Jaydutt Bhalshankar , Tatiana Popova
Breast Cancer Research 16 ( 3) 1 -15

21
2014
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.

Anne Vincent-Salomon , Nadège Gruel , Carlo Lucchesi , Gaëtan MacGrogan
Breast Cancer Research 9 ( 2) 1 -15

149
2007
A prognostic DNA signature for T1T2 node-negative breast cancer patients.

Eléonore Gravier , Gaëlle Pierron , Anne Vincent‐Salomon , Nadège Gruel
Genes, Chromosomes and Cancer 49 ( 12) 1125 -1134

53
2010
Inverted Apical CD24 and Weak EZH2 Expressions Are Phenotypic Characteristics of Pure Invasive Micropapillary Carcinoma of the Breast

Nadège Gruel , Aurélie Cédenot , Marion Richardson , Paul Fréneaux
Open Journal of Pathology 03 ( 02) 85 -95

1
2013
Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma.

Nadège Gruel , Carlo Lucchesi , Virginie Raynal , Manuel J. Rodrigues
European Journal of Cancer 46 ( 13) 2399 -2407

54
2010